Andrew D. Dickinson

Companies

• Gilead SciencesChief financial officer Nov 6, 2019 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GSGilead Sciences GILD164,096 shares²$25.2M at $153.68Sep 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 15, 2026Sold 3,000 shares at $145.29 of Gilead Sciences²
• Sep 10, 2026Shares withheld for tax 1,347 shares at $144.81 of Gilead Sciences³
• Sep 10, 2026Exercised options 2,797 shares of Gilead Sciences³
• Aug 17, 2026Sold 3,000 shares at $138.36 of Gilead Sciences⁴
• Jul 15, 2026Sold 3,000 shares at $129.93 of Gilead Sciences⁵
• Jun 15, 2026Sold 3,000 shares at $125.40 of Gilead Sciences⁶
• Jun 10, 2026Shares withheld for tax 1,341 shares at $121.48 of Gilead Sciences⁷
• Jun 10, 2026Exercised options 2,796 shares of Gilead Sciences⁷
• May 15, 2026Sold 3,000 shares at $132.27 of Gilead Sciences⁸
• Apr 15, 2026Sold 3,000 shares at $140.96 of Gilead Sciences⁹
• Mar 16, 2026Sold 3,000 shares at $144.23 of Gilead Sciences¹⁰
• Mar 10, 2026Shares withheld for tax 3,147 shares at $148.56 of Gilead Sciences¹¹
• Mar 10, 2026Exercised options 6,469 shares of Gilead Sciences¹¹
• Feb 27, 2026Granted 11,090 shares of Gilead Sciences¹²
• Feb 17, 2026Sold 3,000 shares at $154.43 of Gilead Sciences¹³
• Feb 3, 2026Shares withheld for tax 24,802 shares at $143.28 of Gilead Sciences¹⁴
• Feb 3, 2026Granted 44,867 shares of Gilead Sciences¹⁴
• Jan 15, 2026Sold 3,000 shares at $124.31 of Gilead Sciences¹⁵
• Dec 15, 2025Sold 3,000 shares at $122.00 of Gilead Sciences¹⁶
• Dec 10, 2025Shares withheld for tax 1,745 shares at $121.34 of Gilead Sciences¹⁷
• Dec 10, 2025Exercised options 3,693 shares of Gilead Sciences¹⁷
• Nov 17, 2025Sold 2,500 shares at $125.23 of Gilead Sciences¹⁸
• Oct 15, 2025Sold 2,500 shares at $118.08 of Gilead Sciences¹⁹
• Sep 15, 2025Sold 2,500 shares at $113.57 of Gilead Sciences²⁰
• Sep 10, 2025Shares withheld for tax 1,751 shares at $115.25 of Gilead Sciences²¹